|
2019 Journal Article Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryGe, Zhen, Baber, Usman, Claessen, Bimmer E., Chandrasekhar, Jaya, Chandiramani, Rishi, Li, Shawn X., Sartori, Samantha, Kini, Annapoorna S., Rao, Sunil V., Weiss, Sandra, Henry, Timothy D., Kapadia, Samir, Muhlestein, Brent, Strauss, Craig, Toma, Catalin, Defranco, Anthony, Efron, Mark B., Keller, Stuart, Baker, Brian A., Pocock, Stuart, Dangas, George and Mehran, Roxana (2019). Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry. Journal of Thrombosis and Thrombolysis, 48 (1), 42-51. doi: 10.1007/s11239-019-01842-9 |
|
2019 Journal Article Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: insights from the TRANSLATE ACS studyIbrahim, Homam, Kaltenbach, Lisa A., Hess, Connie N., Recchia, Tammy, Effron, Mark B., Stone, Gregg W. and Wang, Tracy Y. (2019). Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: insights from the TRANSLATE ACS study. Catheterization and Cardiovascular Interventions, 93 (4), E204-E210. doi: 10.1002/ccd.27816 |
|
2019 Journal Article The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registryGe, Zhen, Baber, Usman, Claessen, Bimmer E., Farhan, Serdar, Chandrasekhar, Jaya, Li, Shawn X., Sartori, Samantha, Kini, Annapoorna S., Rao, Sunil V., Weiss, Sandra, Henry, Timothy D., Vogel, Birgit, Sorrentino, Sabato, Faggioni, Michela, Kapadia, Samir, Muhlestein, Brent, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Effron, Mark B., Keller, Stuart, Baker, Brian A., Pocock, Stuart, Dangas, George and Mehran, Roxana (2019). The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. Catheterization and Cardiovascular Interventions, 93 (3), E112-E119. doi: 10.1002/ccd.27860 |
|
2019 Journal Article Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromesFaggioni, Michela, Baber, Usman, Chandrasekhar, Jaya, Sartori, Samantha, Weintraub, William, Rao, Sunil V., Vogel, Birgit, Claessen, Bimmer, Kini, Annapoorna, Effron, Mark, Ge, Zhen, Keller, Stuart, Strauss, Craig, Snyder, Clayton, Toma, Catalin, Weiss, Sandra, Aquino, Melissa, Baker, Brian, Defranco, Anthony, Bansilal, Sameer, Muhlestein, Brent, Kapadia, Samir, Pocock, Stuart, Poddar, Kanhaiya L., Henry, Timothy D. and Mehran, Roxana (2019). Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes. Catheterization and Cardiovascular Interventions, 94 (1), 53-60. doi: 10.1002/ccd.28033 |
|
2019 Book Chapter Advances in Cardiovascular Diagnostics Use of Cardiac Biomarkers in Clinical Research and Care of the PatientEffron, Mark B. and Khan, Zahoor (2019). Advances in Cardiovascular Diagnostics Use of Cardiac Biomarkers in Clinical Research and Care of the Patient. Handbook of Biomarkers and Precision Medicine. (pp. 501-513) edited by Carini, C., Fidock, M. and VanGool, A.. Boca Raton, FL United States: CRC Press. |
|
2018 Journal Article Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS StudyChandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Kini, Annapoorna S., Rao, Sunil, Weintraub, William, Henry, Timothy D., Farhan, Serdar, Vogel, Birgit, Sorrentino, Sabato, Ge, Zhen, Kapadia, Samir, Muhlestein, Joseph B., Weiss, Sandra, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Effron, Mark B., Keller, Stuart, Baker, Brian A., Pocock, Stuart, Dangas, George and Mehran, Roxana (2018). Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study. Canadian Journal of Cardiology, 34 (3), 319-329. doi: 10.1016/j.cjca.2017.12.023 |
|
2018 Journal Article The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: insights from the TRANSLATE-ACS studyEffron, Mark B., Wang, Tracy Y., Fonarow, Gregg C., Henry, Timothy D., Zettler, Marjorie E., Baker, Brian A., McCoy, Lisa A. and Peterson, Eric D. (2018). The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: insights from the TRANSLATE-ACS study. Catheterization and Cardiovascular Interventions, 91 (2), 242-250. doi: 10.1002/ccd.27145 |
|
2018 Journal Article Antiplatelet therapy changes for patients with myocardial infarction with recurrent ischemic events: Insights into contemporary practice from the TRANSLATE-ACS (treatment with ADP receptor inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary syndrome) studyFanaroff, Alexander C., Kaltenbach, Lisa A., Peterson, Eric D., Akhter, Mohammed W., Effron, Mark B., Henry, Timothy D. and Wang, Tracy Y. (2018). Antiplatelet therapy changes for patients with myocardial infarction with recurrent ischemic events: Insights into contemporary practice from the TRANSLATE-ACS (treatment with ADP receptor inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary syndrome) study. Journal of the American Heart Association, 7 (4) e007982. doi: 10.1161/JAHA.117.007982 |
|
2018 Journal Article The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease – Where Is the Moon Now?Effron, Mark B. and Gibson, C. Michael (2018). The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease – Where Is the Moon Now?. Progress in Cardiovascular Diseases, 60 (4-5), 457-459. doi: 10.1016/j.pcad.2018.01.011 |
|
2018 Journal Article Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" ExperienceEffron, Mark B. and Gibson, C. Michael (2018). Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience. Progress in Cardiovascular Diseases, 60 (4-5), 531-536. doi: 10.1016/j.pcad.2018.01.010 |
|
2017 Journal Article One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims DatabaseEffron, Mark B., Nair, Kavita V., Molife, Cliff, Keller, Stuart Y., Page, Robert L., Simeone, Jason C., Murphy, Brian, Nordstrom, Beth L., Zhu, Yajun, McCollam, Patrick L. and Vetrovec, George W. (2017). One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database. American Journal of Cardiovascular Drugs , 18 (2), 129-141. doi: 10.1007/s40256-017-0255-y |
|
2017 Journal Article Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS StudyBaber, Usman, Chandrasekhar, Jaya, Sartori, Samantha, Aquino, Melissa, Kini, Annapoorna S., Kapadia, Samir, Weintraub, William, Muhlestein, Joseph B., Vogel, Birgit, Faggioni, Michela, Farhan, Serdar, Weiss, Sandra, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Baker, Brian A., Keller, Stuart, Effron, Mark B., Henry, Timothy D., Rao, Sunil, Pocock, Stuart, Dangas, George and Mehran, Roxana (2017). Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. JACC: Cardiovascular Interventions, 10 (20), 2017-2025. doi: 10.1016/j.jcin.2017.02.047 |
|
2017 Journal Article Multivessel versus culprit vessel-only percutaneous coronary intervention among patients with acute myocardial infarction: Insights from the TRANSLATE-ACS observational studyIbrahim, Homam, Sharma, Praneet K., Cohen, David J., Fonarow, Gregg C., Kaltenbach, Lisa A., Effron, Mark B., Zettler, Marjorie E., Peterson, Eric D. and Wang, Tracy Y. (2017). Multivessel versus culprit vessel-only percutaneous coronary intervention among patients with acute myocardial infarction: Insights from the TRANSLATE-ACS observational study. Journal of the American Heart Association, 6 (10) e006343. doi: 10.1161/JAHA.117.006343 |
|
2017 Journal Article Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction a secondary analysis of the TRANSLATE-ACS studyGuimarães, Patricia O., Krishnamoorthy, Arun, Kaltenbach, Lisa A., Anstrom, Kevin J., Effron, Mark B., Mark, Daniel B., McCollam, Patrick L., Davidson-Ray, Linda, Peterson, Eric D. and Wang, Tracy Y. (2017). Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction a secondary analysis of the TRANSLATE-ACS study. JAMA Cardiology, 2 (7), 750-757. doi: 10.1001/jamacardio.2017.1460 |
|
2017 Journal Article Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyBaber, Usman, Sartori, Samantha, Aquino, Melissa, Kini, Annapoorna, Kapadia, Samir, Weiss, Sandra, Strauss, Craig, Muhlestein, J. Brent, Toma, Catalin, Rao, Sunil V., DeFranco, Anthony, Poddar, Kanhaiya L., Chandrasekhar, Jaya, Weintraub, William, Henry, Timothy D., Bansilal, Sameer, Baker, Brian A., Marrett, Elizabeth, Keller, Stuart, Effron, Mark, Pocock, Stuart and Mehran, Roxana (2017). Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study. American Heart Journal, 188, 73-81. doi: 10.1016/j.ahj.2017.02.013 |
|
2017 Journal Article Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational studyZettler, Marjorie E., Peterson, Eric D., McCoy, Lisa A., Effron, Mark B., Anstrom, Kevin J., Henry, Timothy D., Baker, Brian A., Messenger, John C., Cohen, David J. and Wang, Tracy Y. (2017). Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study. American Heart Journal, 183, 62-68. doi: 10.1016/j.ahj.2016.10.006 |
|
2016 Journal Article Early Cessation of Adenosine Diphosphate Receptor Inhibitors among Acute Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study (Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome)Fosbøl, Emil L., Ju, Christine, Anstrom, Kevin J., Zettler, Marjorie E., Messenger, John C., Waksman, Ron, Effron, Mark B., Baker, Brian A., Cohen, David J., Peterson, Eric D. and Wang, Tracy Y. (2016). Early Cessation of Adenosine Diphosphate Receptor Inhibitors among Acute Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study (Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome). Circulation: Cardiovascular Interventions, 9 (11) e003602. doi: 10.1161/CIRCINTERVENTIONS.115.003602 |
|
2016 Journal Article Impact of proton pump inhibitor use on the comparative effectiveness and safety of prasugrel versus clopidogrel: Insights from the treatment with adenosine diphosphate receptor inhibitors: Longitudinal assessment of treatment patterns and events after acute coronary syndrome (translate-acs) studyJackson, Larry R., Peterson, Eric D., McCoy, Lisa A., Ju, Christine, Zettler, Marjorie, Baker, Brian A., Messenger, John C., Faries, Douglas E., Effron, Mark B., Cohen, David J. and Wang, Tracy Y. (2016). Impact of proton pump inhibitor use on the comparative effectiveness and safety of prasugrel versus clopidogrel: Insights from the treatment with adenosine diphosphate receptor inhibitors: Longitudinal assessment of treatment patterns and events after acute coronary syndrome (translate-acs) study. Journal of the American Heart Association, 5 (10) e003824, 1-11. doi: 10.1161/JAHA.116.003824 |
|
2016 Journal Article Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) StudyVora, Amit N., Peterson, Eric D., Mccoy, Lisa A., Effron, Mark B., Anstrom, Kevin J., Faries, Douglas E., Zettler, Marjorie E., Fonarow, Gregg C., Baker, Brian A., Stone, Gregg W. and Wang, Tracy Y. (2016). Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. Journal of the American Heart Association, 5 (9) e003946. doi: 10.1161/JAHA.116.003946 |
|
2016 Journal Article Comparing inverse probability of treatment weighting and instrumental variable methods for the evaluation of adenosine diphosphate receptor inhibitors after percutaneous coronary interventionFederspiel, Jerome J., Anstrom, Kevin J., Xian, Ying, McCoy, Lisa A., Effron, Mark B., Faries, Douglas E., Zettler, Marjorie, Mauri, Laura, Yeh, Robert W., Peterson, Eric D., Wang, Tracy Y. and for the Treatment With Adenosine Diphosphate Receptor Inhibitors–Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Investigators (2016). Comparing inverse probability of treatment weighting and instrumental variable methods for the evaluation of adenosine diphosphate receptor inhibitors after percutaneous coronary intervention. JAMA Cardiology, 1 (6), 655-665. doi: 10.1001/jamacardio.2016.1783 |
